NCT05397405View on ClinicalTrials.gov

Improving Blood Lipid Management in Symptomatic Intracranial Atherosclerotic Stenosis on Clinical Outcome

NARecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

May 23, 2022

Primary Completion Date

May 1, 2026

Study Completion Date

May 1, 2026

Conditions
Intracranial Artery Stenosis
Interventions
DRUG

PCSK9 inhibitor

The aim is to improve blood lipid management by using atorvastatin 20-40mg or rosuvastatin 10-20mg or simvastatin 20-40mg and PCSK9 inhibitors for 6-12 months

Trial Locations (2)

210006

RECRUITING

Nanjing First Hospital, Nanjing Medical University, Nanjing

RECRUITING

Nanjing First Hospital, Nanjing

All Listed Sponsors
lead

Nanjing First Hospital, Nanjing Medical University

OTHER